Background-Hypertension is a worldwide public health issue with significant comorbidity and
INTRODUCTION
The pathogenesis of cardiovascular diseases (CVD) is multifactorial and complex.
Worldwide, CVD contributes to almost a third (17 million) of the total deaths per year, and the complications of hypertension alone are accountable for over 50% of the CVD-related deaths 1 .
The high global prevalence of hypertension is a major public health issue that requires urgent attention. Prevention of hypertension-related disease using dietary solutions, without the need for pharmacological intervention, is particularly desirable with regard to social and financial management of the population burden of CVD. A number of healthy diets such as the Dietary
Approaches to Stop Hypertension (DASH) 2 , Mediterranean 3 and Optimal Macronutrient
Intake Trial to Prevent Heart Disease (OmniHeart) 4 diets, have been shown to reduce blood pressure (BP); optimize serum lipid profiles; and improve cardiovascular risk scores.
Despite the fact that healthy diets have unequivocally been shown to impact beneficially on health at a population level, at the inter-individual level, the evidence is conflicting 5 .
Investigation of gene-environmental interactions by metabolic phenotyping is an attractive approach as it enables better health outcomes to be achieved using stratification of individuals' disease risks and biological phenotypes 6 . Metabolic phenotyping studies have proven valuable in investigating changes in metabolic phenotypes in response to food intake 7 , evaluating dietary modulation in gastrointestinal cancer risk 8 and in metabolically characterizing BP 9, 10 and obesity 11 . In an attempt to understand this variability in dietary phenotypes, we used proton nuclear magnetic resonance ( 1 H NMR) spectroscopy to assess the 24-h urinary phenotype of 158 individuals in response to three different healthy diets, each consumed for a 6-week period, in a randomized cross-over feeding study. We hypothesized that comparison of healthy diets with a typical American diet or between different healthy diets would result in specific changes in the urinary metabolic phenotypes. We further hypothesize that these specific urinary metabolic phenotypes will be associated with CVD risk factors.
METHODS
The OmniHeart Study (N=164) was a randomized, controlled, cross-over feeding study that assessed the effects of three healthy diets on the BP and lipid profiles of participants. All three
OmniHeart diets had a similar nutrient composition to the established healthy DASH diet but varied in macronutrient composition. The Omniheart carbohydrate-rich diet (OmniCarb diet) provided 58% kcals from carbohydrate, 15% from protein and 27% from fat; the remaining two diets, replaced 10% of calories from carbohydrate with either protein, predominantly obtained from vegetable sources (OmniProt diet), or unsaturated fats, predominantly derived from monounsaturated fat (OmniFat diet). 
Data processing and analysis
Urine specimens were prepared and analyzed by 600 MHz 1 H NMR spectroscopy following standard protocol 12 . The processed spectroscopic data were normalized and modelled using orthogonal partial least squares-discriminant analysis (OPLSDA). Due to the nature of crossover study design, we then employed multilevel OPLSDA (mOPLSDA) 13 17 .
Since we found no significant difference in the excretion of creatinine between different
OmniHeart diets and the typical American diet (P >0.5), the difference in absolute excretion of each discriminatory metabolite between each comparison was adjusted to the corresponding 24-h urinary creatinine excretion (in mmol/L). The association between the changes in discriminatory metabolites and CVD risk was established using Spearman rank correlation for homogeneous responders. In addition, the known covariate for hypertension including urinary sodium, potassium, calcium and phosphate, was also established for homogeneous and variable responders. The statistical significance of Spearman rank correlation was adjusted by Bonferroni correction (0.05/number of comparisons) to account for multiple testing. All analyses were performed using in-house software written in Matlab (version 2012a, MathWorks, Natick, MA).
Full details of the NMR experimental parameters for data processing and multivariate data analysis are provided in Supplementary Information.
RESULTS
OmniHeart diets are associated with distinctive metabolic phenotypes compared to the typical American diet.
Initially, the spectral data were modelled using standard OPLSDA in a pairwise fashion but the differentiation in the urinary spectral data attributable to diet were not captured successfully by We firstly examined the urinary metabolite profiles of the homogeneous subgroups obtained after following each of the OmniHeart diets and compared them to their corresponding baseline metabolic phenotypes using mOPSLDA. The mOPLSDA models for all three diets were highly significant based on permutation testing (P<10 -5 for all homogeneous subgroups) and the discriminatory metabolites characteristic for each of the diets were identified (Supplementary Table 2 ). The origin of the discriminatory metabolites for these three healthy diets over the metabolic profiles at baseline could be predominantly assigned to i) diet: including proline Table 2) .
We compared the 24-h urinary excretion of PB between the homogeneous and variable groups for each pairwise comparison. We found 15 of the 21 individuals (71.4%) from the OmniCarbvar group showed a 24-h urinary excretion of less than 95% confidence interval (CI) of the OmniCarb-homo group. A similar trend was observed for the OmniFat (21/31, 67.7%) and
OmniProt (35/45, 77.8%) variable groups. This gave an estimation of individuals who were potentially non-adherent to each diet based on spectral evidence of lower fruit and polyphenol intake and an overall level of non-adherence of 9.5% to 22.2%, depending of the type of diets.
We excluded those individuals who were deemed non-adherent to the diets and recalculated additional mOPLSDA models using the adherent individuals within the variable subgroups for OmniFat (N=10) and OmniProt (N=10) respectively, but not for OmniCarb-var, due to the small number of participants remaining after exclusion of non-adherent individuals. We found these variable subgroups were generally represented by different urinary phenotypes to the core homogenous subgroups; the OmniProt variable subgroup manifested higher excretion of MCO, NAMCO, and creatine but lower excretion of NAC; while the OmniFat variable subgroup was characterized by higher excretion of hippurate but lower excretion of NAC and unknown metabolite consistent with scyllo-inositol at 3.34s when compared to the corresponding baseline variable subgroups (data not shown).
Urinary Metabolic Variations Reflect Inter-individual Differences in Response to Clinical
Benefits.
We investigated the changes in CVD risk for the homogeneous and variable subgroups separately. The homogeneous groups generally showed a stronger association and a more significant reduction from baseline in CVD risk factors than the variable subgroups for: SBP (- for OmniProt diet, Figure 1 . The OmniHeart diets also showed greater benefit for individuals with higher CVD risk compared to than those with lower risk, e.g. participants who were hypertensive showed a greater reduction in both SBP and DBP than those who were prehypertensive; whilst those with non-optimal lipid profiles showed greater reduction in both triglycerides and TC levels, Supplementary Figure 1 .
For all the variable subgroups, a dampened reduction in CVD risk was observed when compared to the corresponding homogeneous diet subgroups. Nevertheless, for SBP and DBP a significant We also investigated urinary electrolytes known to have an effect on BP. For each OmniHeart diet, we observed significant reduction in urinary sodium and a significant increase in urinary potassium among the homogeneous subgroups, Table 1 . The overall mean changes of urinary sodium and potassium were only significant amongst participants who were hypertensive and showed homogeneous responses to diets. These changes were insignificant for all other subgroups. Trends toward reduced sodium and increased potassium excretion were observed in the variable subgroups, but these changes were typically not significant. Changes in the urinary calcium and phosphate were not statistically significant for any dietary group.
We found that individuals who were consistently classed as a homogeneous responder to all three OmniHeart diets (60.1%, N=95) generally manifested a greater reduction in SBP, DBP, LDL and TC levels than those that showed homogeneous responses to just one or two OmniHeart diets (Supplementary Figure 2) . Similar to the results observed earlier among the homogeneous subgroups to specific OmniHeart diets, the reduction in CVD risk was generally greater in those high risk subgroups e.g. those who were hypertensive or with a non-optimal lipid profile, indicating the potential benefit of these three healthy diets. For the variable subgroup, after excluding spectral data with low urinary excretion of PB, indicating non-adherent, we found 23(14.5%) individuals showed variable responses to one or more OmniHeart diet.
Distinct changes in urinary metabolic phenotype were observed between OmniHeart diets.
Pairwise comparison between OmniHeart diets showed consistent differences in diet-associated metabolic phenotypes (P<10 -5 ). The homogeneous subgroup of OmniProt diet was generally characterized by higher excretion of urinary creatine (indicative of protein intake); M2PY and two gut microbial mammalian co-metabolites, phenylacetylglutamine (PAG) and 4-cresyl sulfate (PCS); whilst the homogeneous subgroup of OmniCarb consistently showed higher excretion of hippurate and guanodinoacetate when compared to other OmniHeart homogeneous subgroups, Supplementary Table 3 and 4. As expected, the differences in the markers for dietary intake of cruciferous vegetables, MCO and NAMCO, and markers for citrus fruit intake, PB, observed when comparing urine of OmniHeart diets with the baseline profiles, were generally not observed for pairwise comparisons between the OmniHeart diets, since all three OmniHeart diets contained more fruits and polyphenols than the baseline diet.
Correlations of 24h Urinary Excretion of Discriminatory Metabolites with CVD Risk Factors
We then quantified the 24-h urinary excretion of the 8 key discriminatory metabolites using the NMR signal and assessed whether there was a direct relationship between the urinary metabolite characteristics for different OmniHeart diets and their reduction in CVD risk factors. We found a significant inverse association between the PB excretion and SBP for both the OmniCarb and
OmniFat diets when compared to baseline, Table 2 . Although a similar trend was observed for the OmniProt diet, this association was not statistically significant. We also found a significant direct association between the changes in the excretion of hippurate with the reduction in SBP for OmniCarb diet when compared to baseline. Although there was a trend in the association between M2PY and the reduction in DBP for OmniCarb diet; and excretion of carnitine with the changes in SBP for OmniProt diet, when compared to baseline, these trends were not significant after correction for multiple testing. No significant associations were observed between the changes in these urinary metabolites and changes in the LDL and TC. Analyses were not performed for HDL and triglycerides as our results showed the changes in these clinical parameters were generally not significant among the homogeneous subgroups for any of the three OmniHeart diets compared to baseline. Significant inverse associations were observed for changes in the excretion of PCS and the reduction in SBP and DBP for the pairwise comparison between OmniProt and OmniFat.
DISCUSSION
Poor diet and other lifestyle factors contribute to the high burden of hypertension and elevated CVD risk. Dietary strategies to improve risk factors are desirable and have led to the development of healthy diets, such as the DASH diet, which is rich in fruits, vegetables and lowfat dairy products and reduced in saturated fat and cholesterol. However, despite the effectiveness of these diets at a population level, there is substantial inter-individual variability.
In this study, we demonstrate a method for stratification of individuals based on diet-specific urinary phenotypes in order to better characterize CVD risk. Using a statistical correlation algorithms, SHOCSY which incorporates stringent Sidák correction to minimise false positive results and identifies a core group of 'homogeneous' responders, we have shown remarkably consistent modulatory effects on the urinary metabolome when individuals adopted healthy dietary patterns. The homogeneous group represented the majority of the participants for each of the healthy OmniHeart diets with a minority group of 'variable' responders. We show that homogeneous group for each diet typically demonstrated stronger correlations between the metabolic response to a healthy diet and improvement in clinical measurements. We identified generic 'markers' for healthy diet deriving directly from the diet itself such as MCO and NAMCO from cruciferous vegetables 19 and PB from citrus fruits 18 
in the homogeneous
OmniHeart diets when compared the typical American diet. When pairwise responses between the different OmniHeart diets were evaluated, these markers were no longer discriminatory since all OmniHeart diets involved increased fruit and vegetable intake when compared to a typical American diet. As expected, higher urinary levels of carnitine and creatine, both known indices of increased protein intake 20 , remained discriminatory in the comparison of the OmniProt and baseline diets as well as the comparisions of OmniProt to OmniCarb and/or OmniFat. The high protein intake of the OmniProt diet (10% kcal higher than the other diets) was likely responsible.
We also observed differences in metabolites related to the tryptophan-NAD pathway: reduced excretion of NMND and M2PY but increased excretion of NMNA among the homogeneous responders to the OmniCarb diet compared to the baseline. Bartus et al found that the ingestion of 1-methylnicotinamide in hypertriglyceridemic rats resulted in an increase of 1-methylnicotinamide and its metabolites such as M2PY, concomitant with a significant reduction in serum triglycerides. They also found that ingestion of 1-methylnicotinamide in both diabetic and hypertriglyceridemic rats ameliorated the nitric oxide dependent vasodilation, a key surrogate marker for atherosclerosis and improved CVD health 21 . Increased urinary excretion M2PY and NMND with a decreased in NMNA has also been observed in type 2 diabetes patients 22 . In contrast, we, and others, did not find such a correlation between urinary excretion and serum lipid profiles 23 .
We observed that the participants in the variable subgroups demonstrated some metabolites
showing an opposing metabolite pattern to the homogeneous groups. These individuals typically showed a dampened clinical response to the dietary interventions. The reasons for variable response to dietary intervention was obvious for some participants, for example, reduced PB excretion appeared to indicate a lack of dietary adherence with respect to citrus fruit intake, as PB is excreted mainly unchanged with the production of some minor metabolites in the urine 24, 25 . We therefore used PB excretion as a proxy marker for non-adherence to the OmniHeart diets and found that the majority of the participants in the variable response groups showed a reduction in 24-h urinary excretion of PB when compared to the homogeneous groups. These individuals corresponded to an overall estimated non-adherence of 9.5% (n=15), 13.3% (n=21) and 22.2% (n=35) for OmniCarb, OmniFat and OmniProt diets, respectively. These values were considerably higher than the <5% non-adherence estimated from the self-reported data 4 . Based on the urinary metabolic phenotypes, identification of individuals showing limited clinical responses due to non-adherence to dietary intervention is therefore made possible. This offers the feasibility of a rational stratification strategy for clinicians to apply an alternative clinical intervention for optimizing CVD risk. We also observed that a small proportion of the individuals in the variable groups who appeared to be adherent to diet, based on the measured PB excretion, remained discordant from the homogeneous subgroups in terms of their metabolic phenotype. These subgroups, albeit small in proportion, may indicate individuals who differ in their metabolism of dietary components from the majority of the population. In these subgroups, we observed diet-specific differences such as hippurate, that exhibited contrasting behaviour in the homogenous and variable groups, and which may be indicative of inter-individual differences in gut-microbial related metabolic activity. We also found the homogenous OmniProt group generally showed an increased excretion of PAG and PCS when compared to other OmniHeart diets but not the typical American diet. The differences in gut-microbial co-metabolites may indicate the differences in putrefaction of protein following an increase in protein content of the OmniProt diet 26 . Numerous studies have reported associations between gut bacteria and obesity, diabetes and BP. Higher urinary excretion of hippurate has generally been associated with lean phenotypes in both animals 27 and humans 11 . A large-scale cross sectional study also reported an inverse association between excretion of hippurate and BP 9 . This is consistent with our observation of increased hippurate excretion following adherence to the OmniCarb diet and its direct association with a reduction in SBP.
Large-scale genome wide association studies have widely demonstrated genetic variation in response to drug treatments, particularly in the areas of anti-cancer 28 and psychotropic drugs 29 .
Similarly, variation in response to diets has also been observed based on genetic studies 30 . These variations in response are mostly attributed to genetic polymorphisms. However, to the best of our knowledge, our study is the first study that shows non-genetic variation in the urinary metabolic phenotype in response to healthy diets. Currently, nutritional recommendations are based on providing an average nutrient requirement and are typically aimed at prevention of chronic diseases and/or maintenance of healthy lifestyle of the general population. However, evidence from our results clearly indicates that approximately 14.5% of the participants did not respond in the 'typical' manner to one or more of the healthy OmniHeart diets despite being adherent to the diets. Extending this concept, one can envisage that further characterization of inter-individual response to healthy diet as determined by individual's phenotypic patterns and further determining an individual's longitudinal phenotypic stability prior to a dietary healthy intervention would need to be developed for the identification of latent sub-phenotypes. This may confer a public health benefit that has the potential to provide a personalized approach to dietary recommendations aimed at optimizing prevention of CVD and related disorders.
While our current study discovered phenotypes associated with BP and healthy dietary patterns, the mechanistic connection between these metabolites and BP regulation require further elucidation. Since by design, the weight of participants remained the same throughout the study, models were not adjusted for body mass index. We also did not adjust for socioeconomic status based on a previous large scale cross sectional study, where years of education were used as a proxy for socioeconomic status, demonstrated that the inverse association with BP was explained mostly by dietary differences 31 . The inclusion of individuals from a high CVD risk group such as African American (~50%) and pre-hypertensive patients (~80%) add strength to the general applicability of our stratification strategy, although we recognize that our findings have not been validated using an independent dataset. Nevertheless, provision of all meals to participants, inclusion of 24-h urine collection, and the randomized cross-over design all add rigor to the study, which represents one of the largest dietary interventions of its kind.
Conclusions
The application of metabolic phenotyping to a landmark dietary intervention study, coupled with statistical stratification of the patient cohorts enabled the identification of individuals who were homogeneous in response to healthy diets and provided a tool for identifying individuals who exhibited a non-uniform response to the diets. While the majority of individuals (>60%)
showed a homogeneous response to all OmniHeart diets, a small proportion of individuals manifested variable dietary responses despite being adherent to the diet. We propose that this difference could be partially attributable to differential gut microbial activities based on the urinary metabolite profiles. Using this NMR-based urinary metabolic phenotyping strategy, differentiation in the excretion of urinary metabolites enabled the assessment of CVD risk factors such as BP. In conclusion, variation in metabolic phenotypes in response to specific diets may hold clues as to the mechanisms underlying inter-individual differences in dietary response and provide a clinically actionable framework to develop tailored dietary interventions designed to reduce BP and CVD risk.
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